ℹ️
🇬🇧
Search
Search for people relevant for "Studies"
Studies
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Luboš Petruželka CSc.
Academic staff at First Faculty of Medicine
8 classes
516 publications
Classes
class
Oncology
+2
B00344 |
First Faculty of Medicine
class
Oncology and Palliative Nursing
+1
B01815 |
First Faculty of Medicine
class
Oncology, Palliative and Hospice Care
B01900 |
First Faculty of Medicine
class
Clinical Oncology for Students of Stomatology
B00096 |
First Faculty of Medicine
class
Nursing in Oncology and Hemato-oncology
B03466 |
First Faculty of Medicine
Publications
publication
PET/CT significance for planning radiotherapy of head and neck cancer
2012 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
publication
Local Treatment of Hand-Foot Syndrome with Uridine/Thymidine: In Vitro Appraisal on a Human Keratinocyte Cell Line HaCaT
2012 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer Single-institution outcome analysis
2012 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy
2011 |
First Faculty of Medicine
publication
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
2010 |
First Faculty of Medicine
publication
Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers.
2010 |
First Faculty of Medicine
publication
Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: A matched controlled study
2009 |
First Faculty of Medicine
publication
Malignant thymoma - our experience with therapy of 92 patients
2009 |
First Faculty of Medicine
publication
Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA
2008 |
First Faculty of Medicine
publication
First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase 2 study
Publication without faculty affiliation
Load more publications (506)
Loading network view...